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Abstract 
Administration of sedatives and opioid analgesics to hospitalized 
patients in the Intensive Care Unit (ICU) is a common event as 
part of the usual process of care. Accidental over-sedation leads to 
increased patient harm, prolonged ICU length of stay, and 
increased healthcare costs. Thus, clinicians must find efficient, 
objective ways to monitor patients’ neurologic status and the 
effects of sedating medications. The Pupillary Light Reflex (PLR) 
and pupil size have traditionally been used for this clinical 
assessment. Digital Video Pupillometry, or Digital Pupillometry 
(DP), is emerging as a potential mechanism for more objective 
monitoring of analgesia and depth of sedation. DP provides rapid 
and precise electronic measurements of baseline and constricted 
pupillary diameters, velocity of contraction, and latency time 
between light exposure and onset of contraction reflex. Further 
research on the many effects of medication on PLR is needed in 
order to continue researching the utility of DP for reliable 
monitoring of ICU sedation. In this paper, we will discuss the 
known effects of various medication classes on pupillary 
musculature as reported in the current literature. 
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Background 
 
For nonverbal patients such as small 
children, intubated intensive care unit (ICU) 
patients, and those with neurologic deficits, it is 
often challenging to assess pain responses and 
sedation levels. Researchers and clinicians have 
become increasingly aware of the urgent need to 
develop and enhance ways of monitoring 
sympathetic and parasympathetic neurologic 
activity via pupil responses. Digital Pupillometry 
(DP) is emerging as a potential mechanism of 
objective monitoring of analgesia and depth of 
sedation, though further studies are needed to 
fully understand how commonly administered 
therapeutic medications may affect this 
measurement.   
 
The autonomic nervous system is 
responsible for regulating pupillary musculature, 
thus controlling the amount of light that enters 
the eye. Respectively, the sympathetic and 
parasympathetic branches of this system dilate 
and constrict the pupil through specific muscle 
innervation in the eye. The pupillary light reflex 
pathway involves signal transmission between 
the retinal ganglion cells, optic nerve, midbrain, 
and short ciliary post-ganglionic nerves 
(Chanques et al., 2006). To begin this process, 
light is perceived by the photosensitive retinal 
ganglion cells. The optic nerve then receives this 
information and refers the message to the 
midbrain. In response, outward stimulation 
through post-ganglionic ciliary nerves contracts 
the circular muscle of the eye [Figure 1].  
 
Pupillary Light Reflex (PLR) and pupil 
size have been traditionally used as clinical 
assessments of neurologic status. In standard 
clinical practice, the PLR is estimated using 
terms like “brisk,” “sluggish,” or “non-reactive,” 
where generally, a decrease in a patient’s level of 
arousal is associated with a decrease in pupil 
diameter and PLR response velocity (Martínez-
Ricarte et al., 2013). Pupillometry has, until now, 
been difficult to objectively quantify. Standard 
manual clinical assessments of pupil size and 
reactivity conducted using a penlight have a high 
rate of error and inter- and intra-observer 
variability (Teasdale & Knill-Jones, 1978; 
Wilson, Amling, Floyd, & McNair, 1988). 
 
The development of the portable, 
cordless, handheld digital pupillometer has 
enabled more sensitive and objective 
measurements of PLR and pupil size, potentially 
increasing the clinical utility of the assessment. 
The digital pupillometer utilizes a standard light 
source intensity to stimulate the PLR. The device 
then records the size of the pupil, the latency of 
response to light, the rate of change (velocity) of 
pupillary diameter, and the minimum and 
maximum diameters of the pupil (PLR 
amplitude) (Fountas et al., 2006; Martínez-
Ricarte et al., 2013). DP is more sensitive than 
the unaided human eye, and studies have shown 
the digital pupillometer to identify minimal PLR 
that might otherwise mistakenly be considered 
“non-reactive” (Larson & Muhiudeen, 1995). 
 
The new science of DP might offer a 
more objective measure of pain or analgesia, 
especially in settings where postoperative pain 
can be difficult to communicate. For example, in 
the ICU, many patients will relate pain scores 
that are inconsistent with their behavior which 
can lead to under- or over-sedation (Larson & 
Sessler, 2012).  Adverse effects of untreated 
post-operative acute pain include limited 
mobility, impaired ventilation, and increased 
stress hormones.  Conversely, overtreatment can 
lead to respiratory toxicity and aggravates 
opioid-induced side effects such as nausea and 
vomiting, ileus, sedation, and hyperalgesia 
(Larson & Sessler, 2012).   
 
To clarify, pupillary dilation response is 
not specific for pain, but rather it is related to any 
stimulus that is strong enough to increase the 
level of arousal. Numerous clinical conditions, 
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medications, and variables, such as the patient’s 
wakefulness, level of ambient light, and time of 
day that a procedure is performed, may alter 
pupillometry data collection. In order to validate 
the dependency of these methods, clinicians 
must consider that pupil size and pupillary 
response to pain are influenced by various 
factors besides pain.  
 
In this paper, we will discuss the effects 
of certain medication classes on pupillary light 
reflexes, focusing mostly on opiates and 
sedatives. Based on a review of literature 
exploring the effects of medications on PLR in 
controlled environments, it is clear that DP 
technology will require health professionals to 
better understand the limitations and potential 
extraneous variables that may affect its 
measurements. This information is foundational 
to future studies of potential applications, patient 
care benefits, and advanced pharmacotherapy in 




Opioids and opioid-like medications have 
the ability to affect pupillary diameter, 
specifically by producing miosis of the eye and 
latency in the PLR. Opioids produce miosis by 
causing an excitatory action on the 
parasympathetic innervation of the pupil 
(Fleigert, Kurth, & Göhler, 2005). When light 
hits the retina of the eye, it elicits a response that 
must go through neural pathways in order to 
reach the brain for interpretation [Figure 1].  The 
Edinger-Westphal nucleus is one of those 
pathways.  It is a nucleus of neurons that 
regulates parasympathetic signals to the iris 
muscles.  Parasympathetic signals in the iris will 
result in miosis.  Opioids suppress the inhibitory 
tract of this nucleus, resulting in more of an 
excitatory response that leads to what can be 
seen as pupil constriction. Furthermore, opioid 
induced miosis occurs in a dose-dependent 
fashion, with higher levels of plasma 
concentrations leading to more profound effects 
on pupil dilation. Several studies have utilized 
pupillometry to demonstrate the aforementioned 
effects of opioids. 
 
Fleigert, et al. (2005) utilized 
pupillometry to study the pharmacodynamic 
effects of tramadol, an opioid-like drug, on PLR. 
In the study, the polymorphism of CYP2D6, a 
member of the cytochrome P450 enzymes 
involved in the metabolism of drugs, was 
analyzed in each participant (n=26) because this 
enzyme mediates the active O-demethylated 
metabolite of tramadol, which is responsible for 
providing its analgesic. Once healthy participants 
were labeled as extensive metabolizers (EM), 
intermediate metabolizers (IM), or poor 
metabolizers (PM), they received oral doses of 
150 mg, 100 mg, or 50 mg tramadol and placebo, 
respectively. DP then captured the amplitude, 
latency, and duration of reaction to light pre-dose 
and post-dose.  
 
The pharmacodynamic effects of 
tramadol were detected using digital 
pupillometry, and the CYP2D6 genotype highly 
influenced these responses. The miotic reaction 
was observed in all participants. However, there 
were differences in the extent of miosis observed 
between the differing metabolizers. The 
maximum mean differences between placebo and 
tramadol doses given to PM, IM, and EM were 
reported as -0.5 mm, -0.8 mm, and -1.1 mm, 
respectively (Fleigert et al., 2005).  The lack of 
miosis in the PM compared to EM can be 
attributed to the fact that there is a lack of 
formation of the active O-demethylated 
metabolite of tramadol.  
 
Furthermore, parameters of dynamic 
pupillometry were also studied. For both EM and 
PM, a decrease of amplitude, velocity of 
constriction, and reaction duration occurred, 
while an increase in latency was observed. 
However, the EM experienced these effects for a 
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much longer time period than the PM, 24 and 8 
hours respectively (Fleigert et al., 2005). 
Therefore, these effects would be important to 
consider when using a DP to assess patients 
receiving tramadol in a clinical setting. 
 
 While the aforementioned studies have 
confirmed that opioids are capable of inducing 
miosis of the pupils and delaying response of the 
light reflex, one particular study questioned 
whether these effects would continue during 
opioid-induced toxicity. Rollins, Feiner, Lee, 
Shah, and Larson examined the effects of 
significant opioid-induced respiratory depression 
with accompanying hypercarbia and hypoxia. 
The sympathetic nervous system is activated 
during states of hypercarbia and hypoxia. 
Theoretically, this would cause the pupils to be 
overcome by sympathetic activation as well, 
causing mydriasis (dilation) of the pupils. 
 
Rollins’ study was designed to determine 
whether or not the sympathetic nervous system 
predominates, which would signify if the light 
reflex remains quantifiable during opioid toxicity 
with associated hypercarbia and hypoxia 
(defined as less than 85% Oxygen saturation). 
Ten healthy volunteers received remifentanil, a 
potent short-acting opioid analgesic as a 
gradually increasing infusion rate followed by 
intermittent boluses until an oxyhemoglobin 
saturation of 85% or less was reached, signifying 
hypoxia and hypercarbia had been reached. 
Arterial blood gases and pupillary measures were 
taken before opioid administration, at maximal 
desaturation, and fifteen minutes after recovery 
(Rollins et al., 2014). 
 
Rollins’ results demonstrated that during 
this time, respiratory rate was profoundly 
depressed and as expected, evidence of 
sympathetic activation was present, indicated by 
significant increases in heart rate (p-
value=<0.0001). However, parasympathetic 
activation of the pupil remained, and all subjects 
were noted to have pupillary miosis occurring, 
with diameters of less than 3mm at the point of 
maximal desaturation (Rollins et al., 2014). 
Furthermore, the light reflex of the pupil was 
significantly diminished compared with pre-drug 
administration baseline measures. As the PCO2 
levels increased, there was a decrease in PLR. 
This relationship shows that as CNS depression 
increases, the pupils are not as responsive to 
changes in light. Therefore, Rollins’ study was 
able to establish that even during high-doses of 
opioid administration, parasympathetic effects of 
the pupil remain, which allows for pupillary 
examination and evaluation of PLR to remain 





In the ICU, benzodiazepines (e.g. 
lorazepam, diazepam, and midazolam) have 
traditionally been used to induce sedation in 
patients, especially as adjunct therapy in 
anesthesia. When combined with an opiate 
analgesic to achieve anesthesia, benzodiazepines 
run the risk of causing major respiratory 
depression, which calls for careful titration of the 
dose and constant monitoring of respiratory rate.  
 
Hou, Samuels, Langley, Szabadi, and 
Bradshaw (2007) performed one DP study using 
either an orally administered placebo or 
diazepam 10mg, with either a sympatholytic or 
parasympatholytic eye drop, to observe the effect 
of benzodiazepines on the PRL and concluded 
that diazepam has no effect on pupillary reflexes. 
Another study performed by the same team 
compared pupillary function as affected by 
diazepam and diphenhydramine, again finding 
that diazepam has no significant effect on 
pupillary response (Hou et al., 2006).  
 
Propofol is another common GABA 
agonist agent used for induction and 
maintenance of sedation in the ICU. When dosed 
4
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correctly, patients achieve a significant level of 
sedation with a rapid rate of recovery due to the 
drug’s pharmacokinetic profile. A study 
performed by Odras-Banderas et al. (2014) 
examining pupillary response in patients where 
they were all sedated with propofol showed 
varied results. In post-operative heart surgery 
patients, all sedated with propofol, about half of 
the sample presented with no pupillary response 
during sedation. Neurological examination was 
normal in 80% of the sampled patients after 
sedation. The study concluded that propofol does 
alter neurological and pupillary response and 
suggested that these DP examinations should not 
be used to make clinical decisions on sedation 




Dexmedetomidine, an alpha-2 
adrenoceptor agonist, is a relatively new sedative 
agent gaining popularity due to its unique 
property of only producing mild cognitive 
impairment (Larson & Talke, 2001). Studies on 
animal subjects have found that alpha-2 
adrenoceptor agonists reduce tonic inhibitory 
tone of cell bodies on the pupilloconstrictor 
neurons and inhibit the pupilloconstrictor 
nucleus via an alpha-2 adrenergic mechanism 
[Figure 1]. Although two opposing actions are 
occurring, the predominant effect of the 
pupilloconstrictor nucleus causes mydriasis to 
occur in both rat and cat subjects. The same 
mechanism of action occurs in humans with one 
difference: the effects of the pupilloconstrictor 
nucleus are not dominant to the effects of 
autoreceptors in human subjects; therefore, 
instead of mydraisis the subjects may experience 
miosis (Koss, 1986).  
 
The Department of Anesthesia and 
Perioperative Medicine at the University of 
California tested this hypothesis on eight healthy 
control subjects (Larson & Talke, 2001). 
Dexmedetomidine was infused via a computer-
controlled pump set to a target plasma 
concentration of 0.6 ng/ml to ensure adequate 
sedation.  Measurements on pupil diameter and 
light reflexes were taken every two minutes 
starting thirty minutes before the administration 
of dexmedetomidine until the discontinuation of 
dexmedetomidine after 45 minutes.  
 
Compared to the data collected pre-
infusion, dexmedetomidine did not affect resting 
pupil diameter significantly, with pre- and post-
demedetomidine pupil sizes measuring 2.0 + 
0.36 and 2.0 + 0.32 respectively.  However, 
dexmedetomidine increased the amplitude of the 
pupillary light reflex from 0.30 + 0.14mm to 
0.37 + 0.12mm compared to pre-infusion values. 
The observed pupillary effects of 
dexomedetomidine on humans in the University 
of California’s study did not coincide with 
previously seen pupillary effects in mice and rats 
given an alpha-2 agonist (Koss, 1986). 
Researchers concluded that pupillary effects of 
dexomedetomidine in human subjects should be 
studied further and cannot be explained via the 
pathway of alpha-2 inhibition from the locus 
coeruleus to the pupilloconstrictor nucleus as 




Documentation on external factors 
causing variations on pupillary reflexes can be 
found dated as far back as 1943, when Skoglund 
wrote about how alcohol dilates the pupil in 
proportion to blood alcohol levels. Hess and Polt 
(1966) found that pleasant taste induces pupil 
dilation. Loud noises have also been found to 
increase pupil diameter due to activation of the 
sympathetic pathway. Barlett, Faw, and Leibert 
(1967) discovered alertness in an individual 
presented with pupillary constriction, whereas 
relaxation was suggested by pupillary dilation 
(Sarbin & Slagle, 1979). The Federal University 
of Maranhao (Brazil) found that men and women 
with moderate to severe anxiety had greater pupil 
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dilation than those with mild to no anxiety, 
though there was no difference in pupil dilation 
between the genders (Bertrand, Garcia, Viera, 
Santos, & Bertrand, 2013).  
 
 When assessing pain in nonverbal 
patients in a realistic setting, it may be difficult 
to control external factors such as taste, anxiety, 
light level, and noise. Thus, it is important to 
investigate and understand patients’ conditions 
and medications, along with the many other 
external factors that can affect a pupillometry 




While sedation is frequently required for 
critically ill patients during routine procedures or 
to alleviate pain and anxiety, over-sedation has 
become a common and unfortunate occurrence. 
Many negative outcomes are associated with 
over-sedation, such as cardiovascular instability, 
immunosuppression, decreased gut motility, 
increased risk of thromboembolic events, and 
prolonged ICU stays. Unfortunately, a subjective 
scoring tool is currently used to monitor sedation 
levels, which has the potential to leave critically 
ill patients over-sedated and at risk.  
 
Digital pupillometry is a promising tool 
that potentially is able to objectify the process of 
monitoring the depth of sedation levels in 
patients by relying on pupil diameter and 
pupillary light reflexes as markers of sedation 
levels. Before implementing the routine use of 
DP, it is important to consider any and all factors 
that may affect patients’ pupil diameters and 
PLR. Medications that are commonly used to 
achieve sedation include general anesthetics, 
opiates, and benzodiazepines. Through previous 
studies, it has been shown that while opiates and 
anesthetics, such as propofol, do have significant 
implications on pupillary musculature, 
benzodiazepines do not. Unique factors to drug 
molecule such as metabolism and patient specific 
sympathetic activation to external stimuli also 
play a critical role in interpreting sedation levels. 
Therefore, clinicians should be vigilant and use 
clinical judgment as we learn more about DP. 
Further research is vital in order to establish the 
potential of implementing the use of DP to 
supplement current sedation scales, such as the 
Richmond agitation sedation scale, and to aid 
clinicians in objectively measuring sedation 
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Figure 1: Pupillary Light Reflex Mechanism  
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